Mohammad Alyami1, Olivia Sgarbura2, Vladimir Khomyakov3, Philipp Horvath4, Giuseppe Vizzielli5, Jimmy So6, Juan Torrent7, Xavier Delgadillo8, David Martin9, Wim Ceelen10, Marc Reymond4, Marc Pocard11, Martin Hübner9. 1. Department of General Surgery and Surgical Oncology, Oncology Center, King Khalid Hospital, Najran, Saudi Arabia. Electronic address: swar_ms@hotmail.com. 2. Department of Surgical Oncology, Cancer Institute in Montpellier, France. 3. Moscow Research Oncological Institute n.a. P.A. Herzen, Thoracoabdominal, Moscow, Russian Federation. 4. University of Tuebingen, Germany. 5. Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy. 6. National University Hospital, Singapore. 7. QTI Comprehensive Cancer Center, Barcelona, Spain. 8. CMC Volta, La Chaux-de-Fonds, Switzerland. 9. Department of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), Switzerland. 10. Ghent University, Belgium. 11. Université de Paris, UMR 1275 CAP Paris-Tech, F-75010, Paris, France; Service de Chirurgie Digestive et Cancérologie Hôpital Lariboisière, 2 rue Ambroise Paré, F-75010, Paris, France.
Abstract
BACKGROUND: PIPAC is a novel mode of intraperitoneal drug delivery for patients with peritoneal cancer (PC). PIPAC is a safe treatment with promising oncological results. Therefore, a structured training program is needed to maintain high standards and to guarantee safe implementation. METHODS: An international panel of PIPAC experts created by means of a consensus meeting a structured 2-day training course including essential theoretical content and practical exercises. For every module, learning objectives were defined and structured presentations were elaborated. This structured PIPAC training program was then tested in five courses. RESULTS: The panel consisted of 12 experts from 11 different centres totalling a cumulative experience of 23 PIPAC courses and 1880 PIPAC procedures. The final program was approved by all members of the panel and includes 12 theoretical units (45 min each) and 6 practical units including dry-lab and live surgeries. The panel finalized and approved 21 structured presentations including the latest evidence on PIPAC and covering all mandatory topics. These were organized in 8 modules with clear learning objectives to be tested by 12 multiple-choice questions. Lastly, a structured quantifiable (Likert scale 1-5) course evaluation was created. The new course was successfully tested in five courses with 85 participants. Mean overall satisfaction with the content was rated at 4.79 (±0.5) with at 4.71 (±0.5) and at 4.61 (±0.7), respectively for course length and the balance between theory and practice. CONCLUSIONS: The proposed PIPAC training program contains essential theoretical background and practical training enabling the participants to safely implement PIPAC.
BACKGROUND:PIPAC is a novel mode of intraperitoneal drug delivery for patients with peritoneal cancer (PC). PIPAC is a safe treatment with promising oncological results. Therefore, a structured training program is needed to maintain high standards and to guarantee safe implementation. METHODS: An international panel of PIPAC experts created by means of a consensus meeting a structured 2-day training course including essential theoretical content and practical exercises. For every module, learning objectives were defined and structured presentations were elaborated. This structured PIPAC training program was then tested in five courses. RESULTS: The panel consisted of 12 experts from 11 different centres totalling a cumulative experience of 23 PIPAC courses and 1880 PIPAC procedures. The final program was approved by all members of the panel and includes 12 theoretical units (45 min each) and 6 practical units including dry-lab and live surgeries. The panel finalized and approved 21 structured presentations including the latest evidence on PIPAC and covering all mandatory topics. These were organized in 8 modules with clear learning objectives to be tested by 12 multiple-choice questions. Lastly, a structured quantifiable (Likert scale 1-5) course evaluation was created. The new course was successfully tested in five courses with 85 participants. Mean overall satisfaction with the content was rated at 4.79 (±0.5) with at 4.71 (±0.5) and at 4.61 (±0.7), respectively for course length and the balance between theory and practice. CONCLUSIONS: The proposed PIPAC training program contains essential theoretical background and practical training enabling the participants to safely implement PIPAC.
Authors: Koen P Rovers; Emma C E Wassenaar; Robin J Lurvink; Geert-Jan M Creemers; Jacobus W A Burger; Maartje Los; Clément J R Huysentruyt; Gesina van Lijnschoten; Joost Nederend; Max J Lahaye; Maarten J Deenen; Marinus J Wiezer; Simon W Nienhuijs; Djamila Boerma; Ignace H J T de Hingh Journal: Ann Surg Oncol Date: 2021-02-05 Impact factor: 5.344
Authors: Olivia Sgarbura; Clarisse Eveno; Mohammad Alyami; Naoual Bakrin; Delia Cortes Guiral; Wim Ceelen; Xavier Delgadillo; Thanh Dellinger; Andrea Di Giorgio; Amaniel Kefleyesus; Vladimir Khomiakov; Michael Bau Mortensen; Jamie Murphy; Marc Pocard; Marc Reymond; Manuela Robella; Koen P Rovers; Jimmy So; S P Somashekhar; Clemens Tempfer; Kurt Van der Speeten; Laurent Villeneuve; Wei Peng Yong; Martin Hübner Journal: Pleura Peritoneum Date: 2022-03-01
Authors: Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger Journal: Ann Surg Oncol Date: 2021-08-13 Impact factor: 5.344